Heartflow, Inc. Common Stock (HTFL) has 8 既知のインサイダーおよび機関投資家保有者の記録. 最大保有者は Bain Capital Life Sciences Investors, LLC 10,448,158 株保有. その他の主要保有者には Farquhar John C.M. および Lightcap Jeffrey C.
過去12ヶ月間にインサイダーは 23 件の取引を実施 HTFL 株式 — 5 件の買い (評価額 $13.33M) および 7 件の売り (評価額 $59.36M). インサイダーの売りが買いを上回っています.
HTFL インサイダー保有状況
最大保有者
Bain Capital Life Sciences Investors, LLC
10,448,158 株
インサイダー上位保有者
| # |
氏名 |
役職 |
保有株数 |
最終申告日 |
相対規模 |
| 1 |
Bain Capital Life Sciences Investors, Llc |
10 Percent Owner |
10,448,158 |
2026-02-06 |
|
| 2 |
Farquhar John C.m. |
Chief Executive Officer |
571,725 |
2026-03-20 |
|
| 3 |
Lightcap Jeffrey C |
Director |
246,261 |
2026-03-26 |
|
| 4 |
Verghese Vikram |
Chief Financial Officer |
119,685 |
2026-02-10 |
|
| 5 |
Rogers Campbell |
Chief Medical Officer |
78,518 |
2026-03-23 |
|
| 6 |
Cullivan Julie A |
Director |
27,291 |
2026-03-06 |
|
| 7 |
Barabe Timothy C |
Director |
15,412 |
2026-03-12 |
|
| 8 |
Jones Marie L. |
Chief Accounting Officer, VP |
10,021 |
2026-02-10 |
|
最近の取引 (過去12ヶ月)
| 日付 |
氏名 |
役職 |
種類 |
株数 |
株価 |
価値 |
| 2026-04-01 |
Rogers Campbell |
Chief Medical Officer |
オプション行使（売却） |
6,849 |
$2.22 |
$15.2K |
| 2026-03-24 |
Lightcap Jeffrey C |
Director |
その他（買い） |
206,261 |
- |
- |
| 2026-03-24 |
Healthcor Partners Management Lp |
Director |
その他（売り） |
4,615,542 |
- |
- |
| 2026-03-19 |
Rogers Campbell |
Chief Medical Officer |
情報に基づく売り |
64,533 |
$25.69 |
$1.66M |
| 2026-03-18 |
Farquhar John C.m. |
Chief Executive Officer |
情報に基づく売り |
9,725 |
$25.00 |
$243.13K |
| 2026-03-10 |
Farquhar John C.m. |
Chief Executive Officer |
情報に基づく売り |
12,837 |
$22.66 |
$290.89K |
| 2026-03-06 |
Farquhar John C.m. |
Chief Executive Officer |
RSU 付与（制限付株式） |
2,631 |
$16.15 |
$42.49K |
| 2026-03-11 |
Barabe Timothy C |
Director |
オプション行使（売却） |
8,667 |
$2.22 |
$19.24K |
| 2026-03-05 |
Cullivan Julie A |
Director |
情報に基づく売り |
9,122 |
$25.00 |
$228.05K |
| 2026-02-17 |
Barabe Timothy C |
Director |
オプション行使（売却） |
2,497 |
$8.33 |
$20.8K |
| 2026-02-12 |
Rogers Campbell |
Chief Medical Officer |
オプション行使（売却） |
39,709 |
$8.33 |
$330.78K |
| 2026-02-06 |
Verghese Vikram |
Chief Financial Officer |
RSU 付与（制限付株式） |
119,685 |
$27.74 |
$3.32M |
| 2026-02-06 |
Jones Marie L. |
Chief Accounting Officer, VP |
RSU 源泉徴収 |
94 |
$27.74 |
$2.61K |
| 2026-02-10 |
Farquhar John C.m. |
Chief Executive Officer |
情報に基づく売り |
22,562 |
$27.46 |
$619.55K |
| 2026-02-06 |
Farquhar John C.m. |
Chief Executive Officer |
RSU 付与（制限付株式） |
321,259 |
$27.74 |
$8.91M |
| 2026-02-06 |
Rogers Campbell |
Chief Medical Officer |
RSU 源泉徴収 |
515 |
$27.74 |
$14.29K |
| 2026-02-05 |
Cullivan Julie A |
Director |
情報に基づく売り |
8,000 |
$27.32 |
$218.56K |
| 2026-02-04 |
Bain Capital Life Sciences Investors, Llc |
10 Percent Owner |
情報に基づく売り |
2,000,000 |
$28.05 |
$56.1M |
| 2025-12-16 |
Lightcap Jeffrey C |
Director |
情報に基づく買い |
40,000 |
$26.34 |
$1.05M |
| 2025-11-07 |
Verghese Vikram |
Chief Financial Officer |
RSU 源泉徴収 |
471 |
$32.56 |
$15.34K |
| 2025-11-07 |
Jones Marie L. |
Chief Accounting Officer, VP |
RSU 源泉徴収 |
81 |
$32.56 |
$2.64K |
| 2025-11-07 |
Farquhar John C.m. |
Chief Executive Officer |
RSU 源泉徴収 |
1,339 |
$32.56 |
$43.6K |
| 2025-11-07 |
Rogers Campbell |
Chief Medical Officer |
RSU 源泉徴収 |
439 |
$32.56 |
$14.29K |
